MDxHealth S.A.
MDXH | NASDAQ
$0.60
$0 (0.00%)
Sep 22, 2026, 1:14 PM ET · Market open
+0.00%
(1D)Rating
Updated: Aug 15, 2026Key Statistics
Market Data
Market Cap $30.67M
1D Range
0.60 0.64
52W Range
0.40 5.33
Valuation (TTM)
PE -1.02
PB -1.01
EV/EBITDA -15.16
Valuation (NTM)
Forward PE 121.00
Forward PEG 0.02
Price Target $2.50
Cash Flow
FCF Yield -18.1%
SBC Adj. FCF Yield -15.6%
SBC Impact -13.6%
Margins
Gross Margin 57.6%
Operating Margin -20.4%
FCF Margin -6.8%
Growth (CAGR)
Revenue 3Y | 5Y 96.5% |
29.2%
Dil EPS 3Y | 5Y 68.1% |
43.0%
FCF 3Y | 5Y 57.6% |
6.6%
Returns
ROA -22.9%
ROE 142.6%
ROIC -16.7%
Financial Health
Net Debt
$77.2M
Current Ratio 1.15
Interest Coverage -1.15
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
MDxHealth SA is a commercial-stage precision diagnostics firm delivering specialized urologic solutions across the globe. Its international footprint includes the United States, various European natio...
Sector Healthcare
Industry Medical - Diagnostics & Research
Employees 364
IPO Date Nov 3, 2021
Website mdxhealth.com
Fiscal Year January - December
Latest News
No news articles available yet.
Analyst Summary
# of Analysts
3
Consensus
Buy
Price Target
$2.50
Upside
+316.67%
Buy (3)
Hold (0)
Sell (0)
Add to Watchlist
Select watchlists to add or remove MDXH